BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 17520425)

  • 1. Magnetic resonance imaging in determination of myocardial ischemia and viability: comparison with positron emission tomography and single-photon emission computed tomography in a porcine model.
    Wang L; Zhu HY; Tian JM; Huang SD; Kong LS; Lu JP
    Acta Radiol; 2007 Jun; 48(5):500-7. PubMed ID: 17520425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging--comparison of the late enhancement technique with positronemission tomography].
    Hunold P; Brandt-Mainz K; Freudenberg L; Vogt FM; Neumann T; Knipp S; Barkhausen J
    Rofo; 2002 Jul; 174(7):867-73. PubMed ID: 12101477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol.
    Kühl HP; Lipke CS; Krombach GA; Katoh M; Battenberg TF; Nowak B; Heussen N; Buecker A; Schaefer WM
    Eur Heart J; 2006 Apr; 27(7):846-53. PubMed ID: 16434414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI assessment of myocardial viability: comparison with other imaging techniques.
    Baer FM; Theissen P; Schneider CA; Kettering K; Voth E; Sechtem U; Schicha H
    Rays; 1999; 24(1):96-108. PubMed ID: 10358387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of myocardial viability in ischemic heart disease by cardiac magnetic resonance imaging.
    Muellerleile K; Barmeyer A; Groth M; Lund GK
    Minerva Cardioangiol; 2008 Apr; 56(2):237-49. PubMed ID: 18319702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction.
    Ibrahim T; Bülow HP; Hackl T; Hörnke M; Nekolla SG; Breuer M; Schömig A; Schwaiger M
    J Am Coll Cardiol; 2007 Jan; 49(2):208-16. PubMed ID: 17222732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of myocardial scarring on nonstress delayed-contrast-enhancement cardiac magnetic resonance imaging correlates directly with degrees of resting regional dysfunction in chronic ischemic heart disease.
    Srichai MB; Schvartzman PR; Sturm B; Kasper JM; Lieber ML; White RD
    Am Heart J; 2004 Aug; 148(2):342-8. PubMed ID: 15309007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of echocardiographic two-dimensional speckle tracking longitudinal strain imaging for viability assessment in patients with chronic ischemic left ventricular dysfunction and comparison with contrast-enhanced magnetic resonance imaging.
    Roes SD; Mollema SA; Lamb HJ; van der Wall EE; de Roos A; Bax JJ
    Am J Cardiol; 2009 Aug; 104(3):312-7. PubMed ID: 19616660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability.
    Kwong RY; Korlakunta H
    Top Magn Reson Imaging; 2008 Feb; 19(1):15-24. PubMed ID: 18690157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial viability testing in patients with severe left ventricular dysfunction by SPECT and PET.
    Demirkol MO
    Anadolu Kardiyol Derg; 2008 Nov; 8 Suppl 2():60-70. PubMed ID: 19028637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial viability imaging and revascularization in chronic ischemic left ventricular systolic dysfunction.
    Tajouri TH; Chareonthaitawee P
    Expert Rev Cardiovasc Ther; 2010 Jan; 8(1):55-63. PubMed ID: 20014935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of myocardial viability.
    Beller GA
    Curr Opin Cardiol; 1997 Sep; 12(5):459-67. PubMed ID: 9352173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of scar thickness on the assessment of viability using dobutamine echocardiography and thallium single-photon emission computed tomography: a comparison with contrast-enhanced magnetic resonance imaging.
    Nelson C; McCrohon J; Khafagi F; Rose S; Leano R; Marwick TH
    J Am Coll Cardiol; 2004 Apr; 43(7):1248-56. PubMed ID: 15063438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI for the assessment of myocardial viability.
    Weinsaft JW; Klem I; Judd RM
    Cardiol Clin; 2007 Feb; 25(1):35-56, v. PubMed ID: 17478239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is postsystolic shortening a marker of viability in chronic left ventricular ischemic dysfunction? Comparison with late enhancement contrast magnetic resonance imaging.
    Lim P; Pasquet A; Gerber B; D'Hondt AM; Vancraeynest D; Guéret P; Vanoverschelde JL
    J Am Soc Echocardiogr; 2008 May; 21(5):452-7. PubMed ID: 18029142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrate administration increases blood flow in dysfunctional but viable myocardium, leading to improved assessment of myocardial viability: A PET study.
    Slart RH; Agool A; van Veldhuisen DJ; Dierckx RA; Bax JJ
    J Nucl Med; 2006 Aug; 47(8):1307-11. PubMed ID: 16883010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head-to-head comparison between contrast-enhanced magnetic resonance imaging and dobutamine magnetic resonance imaging in men with ischemic cardiomyopathy.
    Kaandorp TA; Bax JJ; Schuijf JD; Viergever EP; van Der Wall EE; de Roos A; Lamb HJ
    Am J Cardiol; 2004 Jun; 93(12):1461-4. PubMed ID: 15194013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional outcome after revascularization in patients with chronic ischemic heart disease: a quantitative late gadolinium enhancement CMR study evaluating transmural scar extent, wall thickness and periprocedural necrosis.
    Bondarenko O; Beek AM; Nijveldt R; McCann GP; van Dockum WG; Hofman MB; Twisk JW; Visser CA; van Rossum AC
    J Cardiovasc Magn Reson; 2007; 9(5):815-21. PubMed ID: 17891620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of myocardial viability: review of the clinical significance.
    Ramos M; DePasquale E; Coplan NL
    Rev Cardiovasc Med; 2008; 9(4):225-31. PubMed ID: 19122580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of hibernating myocardium in ischemic left ventricular dysfunction.
    Schinkel AF; Bax JJ; Delgado V; Poldermans D; Rahimtoola SH
    Am J Med; 2010 Nov; 123(11):978-86. PubMed ID: 21035587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.